BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Sensible Biotechnologies Slashes Time Taken to Optimize Novel Cell-Based mRNA Therapeutics by More Than 90% with AI Platform Built on NVIDIA Technology

  June 12, 2025

   · 

  2 min read
• Press Releases

  Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics

  June 12, 2025

   · 

  5 min read
• Press Releases

  Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum

  June 12, 2025

   · 

  1 min read
• Press Releases

  Arthrosi Presents Positive Long-Term Safety and Efficacy Data for Pozdeutinurad (AR882) at the European Alliance of Associations for Rheumatology (EULAR) Congress 2025

  June 12, 2025

   · 

  5 min read
• Press Releases

  HOYA Vision Care Unveils Updates from the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting

  June 12, 2025

   · 

  4 min read
• Press Releases

  Sky Labs at Forefront of Cuffless Blood Pressure Monitoring

  June 12, 2025

   · 

  2 min read
• Press Releases

  Lisata Therapeutics to Present at the 2025 BIO International Convention

  June 12, 2025

   · 

  1 min read
• Press Releases

  Hoth Therapeutics Launches Expanded Access Initiative for HT-001, Offering Critical Relief to Cancer Patients Facing Severe Skin Toxicities

  June 12, 2025

   · 

  6 min read
• Press Releases

  Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations

  June 12, 2025

   · 

  6 min read
• Press Releases

  Avidity Biosciences to Present Topline Data from Phase 1/2 FORTITUDE™ Trial of Del-brax in People Living with Facioscapulohumeral Muscular Dystrophy at 32nd Annual FSHD Society International Research Congress

  June 12, 2025

   · 

  4 min read